Actual and Perceived Risk of Cardiovascular Disease among Sample of Iraqi Patients with Rheumatoid Arthritis | [Journal of Pioneering Medical Sciences • 2024]

Author(s):

1. Istabraq Satam Hamoud: Rheumatology Department, Kirkuk Teaching Hospital, Ministry of Health/Environment,,Iraq

2. Nizar Abdulateef Jassim: College of Medicine, University of Baghdad,Baghdad,Iraq

Abstract:

Background: Independent of conventional risk factors, patients with rheumatoid arthritis (RA) have a significantly increased risk of cardiovascular disease (CVD). Aims of the Study: To evaluate the actual and perceived 10-year CVD risk among Iraqi patients with RA as well as their level of knowledge about CVD risk. Patients and methods: This cross-sectional study included 100 RA patients (85 females and 15 males) who visited Baghdad Teaching Hospital/Rheumatology Unit from January 2021 to July 2021. The Framingham Risk Score (FRS) was used to calculate the actual 10-year risk of CVD. The Heart Disease Fact-Rheumatoid Arthritis Questionnaire (HDFQ-RA) was used to assess the subjects' knowledge of cardiovascular disease. Results: Among hundred Iraqi patients with RA, the median age was 51.23 ± 8.4 years. The study's findings revealed that 23% had a high risk for CVD and 27% & 50% had moderate and low risk, respectively, based on the FRS calculator. The risk of CVD was significantly affected by the age of disease onset and seropositivity and steroid use (p-value 0.001). When the perceived risk was compared to the actual risk of cardiovascular disease, there was a weak agreement between them; only 31% had corresponding answers. Conclusions: The study showed an elevated risk of CVD in rheumatoid arthritis patients and a gap between actual and perceived CVD risk.

Page(s): 58-65

DOI: 10.61091/jpms202413110

Published: Journal: Journal of Pioneering Medical Sciences, Volume: 13, Issue: 1, Year: 2024

Keywords:

Rheumatoid Arthritis , Cardiovascular disease risk , Iraq , Framingham risk score FRS

References:

[1] Aviña-Zubieta J. A.,Choi H. K.,Sadatsafavi M.,Etminan M.,Esdaile J. M.,Lacaille D. .2008 .Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Care & Research, 59(12) : 1690-1697.

[2] Gonzalez A.,Maradit Kremers,Crowson H.,Nicola C. S.,Davis P. J.,III P. J.,Therneau J. M.,Gabriel T. M.,S. E. T. M. .2007 .The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 56(11) : 3583-3587.

[3] Lindhardsen J.,Ahlehoff O.,Gislason G. H.,Madsen O. R.,Olesen J. B.,Torp-Pedersen C.,Hansen P. R. .2011 .The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Annals of the Rheumatic Diseases, 70(6) : 929-934.

[4] Roman M. J.,Moeller E.,Davis A.,Paget S. A.,Crow M. K.,Lockshin M. D.,Salmon J. E. .2006 .Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Annals of Internal Medicine, 144(4) : 249-256.

[5] Park Y. B.,Ahn C. W.,Choi H. K.,Lee S. H.,Lee B. H.,Lee H. C.,S. K. H. C. .2002 .Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 46(7) : 1714-1719.

[6] Chung C. P.,Oeser A.,Raggi P.,Gebretsadik T.,Shintani A. K.,Sokka T.,Stein C. M. .2005 .Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 52(10) : 3045-3053.

[7] Aubry M. C.,Maradit-Kremers H.,Reinalda M. S.,Crowson C. S.,Edwards W. D.,Gabriel S. E. .2007 .Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. The Journal of Rheumatology, 34(5) : 937-942.

[8] Balanescu S.,Calmac L.,Constantinescu D.,Marinescu M.,Onut R.,Dorobantu M. .2010 .Systemic inflammation and early atheroma formation: are they related?. Maedica, 5(4) : 292-301.

[9] Maradit-Kremers H.,Crowson C. S.,Nicola P. J.,Ballman K. V.,Roger V. L.,Jacobsen S. J.,Gabriel S. E. .2005 .Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 52(2) : 402-411.

[10] Rho Y. H.,Chung C. P.,Solus J. F.,Raggi P.,Oeser A.,Gebretsadik T.,Stein C. M. .2010 .Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis. Arthritis & Rheumatism, 62(5) : 1259-1264.

[11] Charles-Schoeman C.,Yin Lee Y.,Shahbazian A.,Wang X.,Elashoff D.,Curtis J. R.,Reddy S. T. .2017 .Improvement of high-density lipoprotein function in patients with early rheumatoid arthritis treated with methotrexate monotherapy or combination therapies in a randomized controlled trial. Arthritis & Rheumatology, 69(1) : 46-57.

[12] George M. D.,Giles J. T.,Katz P. P.,England B. R.,Mikuls T. R.,Michaud K.,Baker J. F. .2017 .Impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis. Arthritis care & research, 69(12) : 1789-1798.

[13] DeMizio D. J.,Geraldino-Pardilla L. B. .2020 .Autoimmunity and inflammation link to cardiovascular disease risk in rheumatoid arthritis. Rheumatology and Therapy, 7 : 19-33.

[14] Giles J. T.,Danielides S.,Szklo M.,Post W. S.,Blumenthal R. S.,Petri M.,Bathon J. M. .2015 .Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis. Arthritis & Rheumatology, 67(3) : 626-636.

[15] Avina-Zubieta J. A.,Abrahamowicz M.,De Vera M. A.,Choi H. K.,Sayre E. C.,Rahman M. M.,Lacaille D. .2013 .Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology, 52(1) : 68-75.

[16] Wan E. Y. F.,Yu E. Y. T.,Chan L.,Mok A. H. Y.,Wang Y.,Chan E. W. Y.,Lam C. L. K. .2023 .Comparative Risks of Nonsteroidal Antiinflammatory Drugs on Cardiovascular Diseases: A Population-Based Cohort Study. The Journal of Clinical Pharmacology, 63(1) : 126-134.

[17] Medicines Agency European .2006 .: European Medicines Agency review concludes positive benefit-risk balance for non-selective NSAID's www. ema.europa.eu/en/news/european-medicines-agency-starts-new-review. , : .

[18] Choi H. K.,Hernán M. A.,Seeger J. D.,Robins J. M.,Wolfe F. .2002 .Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. The Lancet, 359(9313) : 1173-1177.

[19] Suissa S.,Bernatsky S.,Hudson M. .2006 .Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Care & Research: Official Journal of the American College of Rheumatology, 55(4) : 531-536.

[20] van Halm V. P.,Nurmohamed M. T.,Twisk J. W.,Dijkmans B. A.,Voskuyl A. E. .2006 .Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Research & Therapy, 8, : 1-6.

[21] Singh S.,Fumery M.,Singh A. G.,Singh N.,Prokop L. J.,Dulai P. S.,Curtis J. R. .2020 .Comparative risk of cardiovascular events with biologic and synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis care & Research, 72(4) : 561-576.

[22] Park B,Ernst D .2021 .-alerts-and-recalls/. , : .

[23] Arts E. E. A.,Popa C.,Den Broeder,Semb A. A.,Toms A. G.,Kitas T.,Fransen G. D.,J. G. D. .2015 .Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases, 74(4) : 668-674.

[24] Kawai V. K.,Chung C. P.,Solus J. F.,Oeser A.,Raggi P.,Stein C. M. .2015 .Brief report: the ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores. , : .

[25] Agca R.,Heslinga S. C.,Rollefstad S.,Heslinga M.,McInnes I. B.,Peters M. J. L.,Nurmohamed M. T. .2017 .EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Annals of the Rheumatic Diseases, 76(1) : 17-28.

[26] Semb A. G.,Ikdahl E.,Wibetoe G.,Crowson C.,Rollefstad S. .2020 .Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis. Nature Reviews Rheumatology, 16(7) : 361-379.

[27] Pak S. .2020 .Primary care providers' awareness, knowledge, and practice with regard to cardiovascular risk in patients with rheumatoid arthritis: PCPs' awareness, knowledge, and practice with regard to CV risks in patients with RA. Clinical Rheumatology, 39 : 755-760.

[28] Arnett D. K.,Blumenthal R. S.,Albert M. A.,Buroker A. B.,Goldberger Z. D.,Hahn E. J.,Ziaeian B. .2019 .AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 140(11) : e596-e646.

[29] .2000 .Obesity: Preventing and Managing the Global Epidemic. , : .

[30] Anderson J.,Caplan L.,Yazdany J.,Robbins M. L.,Neogi T.,Michaud K.,Kazi S. .2012 .Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care & Research, 64(5) : 640-647.

[31] Risk Score Framingham .2020 .. Assessed at 5th December, : .

[32] Ocon A. J.,Reed G.,Pappas D. A.,Curtis J. R.,Kremer J. M. .2021 .Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 80(12) : 1522-1529.

[33] Chhibber A.,Hansen S.,Biskupiak J. .2021 .Statin use and mortality in rheumatoid arthritis: an incident user cohort study. Journal of Managed Care & Specialty Pharmacy, 27(3) : 296-305.

[34] Michos E. D.,Nasir K.,Braunstein J. B.,Rumberger J. A.,Budoff M. J.,Post W. S.,Blumenthal R. S. .2006 .Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis, 184(1) : 201-206.

Citations

Downloads

Views